Robertson D M, Suginami H, Montes H H, Puri C P, Choi S K, Diczfalusy E
Acta Endocrinol (Copenh). 1978 Nov;89(3):492-505. doi: 10.1530/acta.0.0890492.
The presence of an hCG-like material in urinary and pituitary extracts and plasma obtained from non-pregnant subjects was investigated. Two assay methods were used to detect this material following fractionation of pituitary and urinary extracts by gel filtration (Ultrogel AcA 54) and/or isoelectrofocusing: a) a radioimmunoassay employing an antiserum raised against a specific sequence of the carboxy terminal region (residues 115--145) of the beta-subunit of hCG, and b) an in vitro bioassay method which measures both hLH and hCG activities. The fractionation procedures employed provide a satisfactory separation of highly purified hCG and hLH preparations. In the pituitary and urinary extracts hCG beta-peptide-like immunoactive (PIA) material was found consistently, which co-eluted with iodinated hCG following gel filtration and possessed pI values similar to those of hCG when subjected to isoelectrofocusing. The PIA material also exhibited in vitro biological activity similar to that shown by hLH and hCG. Detectable levels of immunoactive material were also found in plasma; however, the plasma levels of this PIA material were not influenced by classical endocrine measures such as the stimulation or inhibition of gonadotrophin secretion. The low levels of this material in plasma precluded its further characterization by gel filtration or electrofocusing. Whereas the present data and those reported by other investigators seem to suggest the presence of some hCG-like material in urinary and pituitary extracts and possibly in plasma of non-pregnant subjects, it is emphasized that the available evidence is not sufficiently conclusive to exclude other interpretations as to the nature of this material.
对从非妊娠受试者获得的尿液、垂体提取物及血浆中是否存在人绒毛膜促性腺激素(hCG)样物质进行了研究。在通过凝胶过滤(Ultrogel AcA 54)和/或等电聚焦对垂体提取物和尿液提取物进行分级分离后,使用两种检测方法来检测这种物质:a)一种放射免疫测定法,采用针对hCGβ亚基羧基末端区域(残基115 - 145)特定序列产生的抗血清;b)一种体外生物测定法,可同时测量人促黄体生成素(hLH)和hCG的活性。所采用的分级分离程序能令人满意地分离出高度纯化的hCG和hLH制剂。在垂体提取物和尿液提取物中始终发现有hCGβ肽样免疫活性(PIA)物质,经凝胶过滤后,该物质与碘化hCG共洗脱,等电聚焦时其等电点值与hCG相似。该PIA物质在体外还表现出与hLH和hCG相似的生物活性。在血浆中也发现了可检测水平的免疫活性物质;然而,这种PIA物质的血浆水平不受经典内分泌措施(如促性腺激素分泌的刺激或抑制)的影响。血浆中该物质的低水平使其无法通过凝胶过滤或电聚焦进行进一步鉴定。虽然目前的数据以及其他研究者报告的数据似乎表明在尿液、垂体提取物中以及可能在非妊娠受试者的血浆中存在一些hCG样物质,但需要强调的是,现有证据尚不足以确凿地排除对该物质性质的其他解释。